Publications by authors named "Rudy Cedillos"

α-synuclein dysregulation is a critical aspect of Parkinson's disease pathology. Recent studies have observed that α-synuclein aggregates are cytotoxic to cells in culture and that this toxicity can be spread between cells. However, the molecular mechanisms governing this cytotoxicity and spread are poorly characterized.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is characterized by neuronal cell death and atrophy in regions of the adult brain, including the hippocampus and cortex, due to formation of amyloid beta (Aβ) plaques and neurofibrillary tangles. The presence of these pathologies can limit normal signaling properties and ultimately lead to learning and memory deficits. Chronic inflammation has been implicated in the onset and progression of these AD-related pathologies.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Rudy Cedillos"

  • - Rudy Cedillos' research primarily focuses on the molecular mechanisms associated with neurodegenerative diseases, particularly Alzheimer's and Parkinson's diseases, examining how certain proteins and inflammatory processes contribute to cell toxicity and cognitive deficits.
  • - His study on α-synuclein reveals that its dysregulation leads to lysosomal rupture, which results in the release of reactive oxygen species, a key factor in the cytotoxicity observed in Parkinson's disease pathology.
  • - Cedillos also explores the impact of chronic inflammation on Alzheimer's disease, demonstrating how repeated endotoxin exposure elevates amyloid beta levels in the hippocampus, subsequently leading to cognitive impairments.